More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
No evidence of more serious illness from COVID-19 among Q fever patients There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.
Specific group of patients with impaired immunity invited in October for third COVID-19 vaccination From 6 October on, a specific group of people with severely impaired immunity (immunocompromised patients) will receive their invitation for a third vaccination against COVID-19.
Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
Preparations for COVID-19 vaccinations now in progress RIVM is preparing for implementation of the coronavirus vaccinations. As soon as there is a safe and effective vaccine against the novel coronavirus, it will be quickly and carefully deployed to vaccinate the target groups.
R number rises to 1, decrease in newly reported COVID-19 infections slows In the past week, the Municipal Health Services (GGDs) reported 36,931 new reports of confirmed COVID infections. This is about the same as in the previous week, when 37,706 new COVID-19 infections were reported (-2%).
New data on antimicrobial resistance in Europe New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw
Second wave is subsiding far slower than the first wave For the second week in a row, the number of newly reported COVID-19 infections decreased last week compared to the week before that.
Patient infected with West Nile virus in the Arnhem region In the past week, six human infections with the West Nile virus have been detected in the Netherlands.